Showing results (91-100 of 107) with videos related to
Sort By:
Pageof 11
Bone Marrow Transplantation|December 25, 2021
Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patientsWolfgang A Bethge, Matthias Eyrich, Stephan Mielke, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2013
Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor changeMaximilian Christopeit, Oliver Kuss, Jürgen Finke, et al.Frontiers in Immunology|February 11, 2021
The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter AnalysisDaphne Mytilineos, Chrysanthi Tsamadou, Christine Neuchel, et al.Blood|November 5, 2016
Matching for the MICA-129 polymorphism is beneficial in unrelated hematopoietic stem cell transplantationDaniel Fuerst, Christine Neuchel, Dietger Niederwieser, et al.Transplantation and Cellular Therapy|August 28, 2022
Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic LeukemiaDietrich W Beelen, Renate Arnold, Matthias Stelljes, et al.Journal of Hematology & Oncology|June 26, 2017
Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMTEolia Brissot, Myriam Labopin, Matthias Stelljes, et al.Journal of Cancer Research and Clinical Oncology|April 11, 2014
Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemiaMarkus Pfirrmann, Susanne Saussele, Andreas Hochhaus, et al.Blood|December 8, 2009
Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IVSusanne Saussele, Michael Lauseker, Alois Gratwohl, et al.British Journal of Haematology|February 29, 2020
Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMTDonal P McLornan, Vittoria Malpassuti, Anne Lippinkhof-Kozijn, et al.European Journal of Haematology|April 21, 2023
Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP-EBMT studyNico Gagelmann, Dirk-Jan Eikema, Linda Koster, et al.Pageof 11